Osteopetrosis: Pathogenesis and rationale for the use of interferon-γ-1b

BioDrugs

Volumn 7, Issue 1, 1997, Pages 23-29

  Shankar, Lakshmi ^a   Gerritsen, Egbert J A ^b   Key Jr , L Lyndon ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; COLONY STIMULATING FACTOR 1; GAMMA1B INTERFERON; IMMUNOMODULATING AGENT; OXYGEN RADICAL; PARATHYROID HORMONE; PREDNISONE; RECOMBINANT GAMMA INTERFERON; SUPEROXIDE; UNCLASSIFIED DRUG;

ALBERS SCHOENBERG DISEASE; BONE MARROW TRANSPLANTATION; CALCIUM METABOLISM; HUMAN; OSTEOCLAST; OSTEOLYSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0030757144     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-199707010-00004     Document Type: Review

References (35)

1. Dent CE, Smellie JM, Watson L. Studies in osteopetrosis. Arch Dis Child 1965; 40: 7-15
2. Shapiro F, Glimcher MJ, Holtrop ME, et al. Human osteopetrosis: a histological, ultrastructural, and biochemical study. J Bone Joint Surg 1980; 62: 384-99
3. Brown DM, Dent PB. Pathogenesis of osteopetrosis. A comparison of human and animal spectra. Pediatr Res 1971; 5: 181-91
4. Key Jr LL, Carnes D, Cole S, et al. Treatment of congenital osteopetrosis with high-dose calcitriol. N Engl J Med 1984; 310: 409-15
5. Gerritsen EJA, Vossen JM, G. van Loo IH. Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics 1994; 93: 247-53
6. Reeves JD, August CS, Humbert JR, et al. Host defense in infantile osteopetrosis. Pediatrics 1979; 64: 202-6
7. Beard CJ, Key LL, Newburger PE, et al. Neutrophil defect associated with malignant infantile osteopetrosis. J Lab Clin Med 1986; 108: 498-505
8. Helfrich MH, Thensingh SW, Nimret RHP, et al. Osteoclast generation from fetal bone marrow cultures in co-culture with murine fetal long bones [abstract]. Cell Tissue Res 1987; 249: 159
9. Garrett IR, Boyce BF, Oreffo ROC, et al. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 1990; 85: 632-9
10. Key LL, Ries WL, Taylor RG, et al. Oxygen-derived free radicals in osteoclasts: the specificity and location of the nitroblue tetrazolium reaction. Bone 1990; 11: 115-9
11. Key LL. Osteopetrosis: a genetic window into osteoclast function. A CPC series. Cases Metab Bone Dis 1987; 2: 1-7
12. Reeves JD, Huffer WE, August CS, et al. The hematopoietic effects of prednisone therapy in four infants with osteopetrosis. J Pediatr 1979; 94: 210-4
13. Dorantes LM, Mejia AM, Dorantes S. Juvenile osteopetrosis: effects on blood and bone of prednisone and a low calcium, high phosphate diet. Arch Dis Child 1986; 61: 666-70
14. Silberman M, Moar G. Mechanisms of glucocorticoid-induced growth retardation: impairment of cartilage mineralization [abstract]. Acta Anat 1978; 101: 140
15. Hahn TJ, Halstead LR, Baran DT. Effects of short term glucocorticoid administration and intentional calcium absorption and circulating vitamin D metabolic concentration in man [abstract]. J Clin Endocrinol Metab 1981; 52: 11
16. Aarskog D, Asknes L, Haneberg B, et al. Acute response of parathyroid hormone in congenital osteopetrosis. Acta Paediatr Scand 1979; 277 Suppl.: 75-80
17. Glorieux FH, Pettifor JM, Marie PJ, et al. Induction of bone resorption by parathyroid hormone in congenital malignant osteopetrosis. Metab Bone Dis Relat Res 1981; 3: 143-50
18. Van Lie Peters EM, Aronson DC, Everts V, et al. Failure of calcitriol treatment in a patient with malignant osteopetrosis. Eur J Pediatr 1993; 152: 818-21
19. 3 and interferon gamma. J Pediatr 1993; 123: 264-8
20. 2, and osteoclast activating factor with parathyroid hormone on the ultrastructure of osteoclasts in cultured long bones of fetal rats. Calcif Tissue Int 1979; 29: 201-5
21. Key LL, Carnes DL, Weichselbaum R, et al. Calcitriol stimulates osteosarcoma cells to produce a factor which increases monocyte-dependent bone resorption [abstract]. Calcif Tissue Int 1983; 35: 696
22. Ballet JJ, Griscelli C, Contris C, et al. Bone-marrow transplantation in osteopetrosis. Lancet 1977; II: 1137
23. Sorrell M, Kapoor N, Kirkpatrick D. Marrow transplantation for juvenile osteopetrosis. Am J Med 1981; 70: 1280-7
24. Coccia PF, Krivit W, Cervenka J, et al. Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med 1980; 302: 701-8
25. Walker DG. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science 1975; 190: 784
26. Gerritsen EJA, Vossen JM, Fasth A, et al. Bone marrow transplantation for autosomal recessive osteopetrosis. J Pediatr 1994; 125: 896-902
27. Wagner JE, Kernan NA, Steinbuch M, et al. Allogenic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995; 346: 214-19
28. Ezekowitz RAB, Orkin S, Newberger PN. Recombinant interferon gamma augments phagocyte superoxide production and gene expression in x-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med 1988; 319: 146-51
29. Key LL, Ries WL, Rodriguiz R, et al. Interferon gamma stimulates bone resorption in the microphthalmic mouse via production of superoxide by NADPH oxidase [abstract]. J Bone Miner Res 1994; 9 Suppl. 1: A108
30. Key LL, Rodriguiz RM, Willi SM, et al. Long-term treatment of osteopetrosis with interferon gamma. N Engl J Med 1995; 332: 1594-9
31. Key Jr LL, Ries WL, Rodriguiz RM, et al. Recombinant human interferon gamma therapy for osteopetrosis. J Pediatr 1992; 121: 119-24
32. Felix R, Cecchini MG, Hofstetter W, et al. Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res 1990; 5: 781-9
33. Chong KT, Langlois L, Doyle L. Recombinant human macrophage colony-stimulating factor (M-CSF) enhanced murine splenic natural-killer (NK) cell activity [abstract]. FASEB J 1989;3: A816
34. M-CSF treatment protocol. New York: Memorial Sloan Kettering Hospital, 1992
35. Shapiro F, Key LL, Anast CS. Variable osteoclast appearance in human infantile osteopetrosis. Calcif Tissue Int 1988; 43: 67-76